These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 16159882
1. A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers. Fan T, Varghese G, Nguyen T, Tse R, O'Dowd BF, George SR. J Biol Chem; 2005 Nov 18; 280(46):38478-88. PubMed ID: 16159882 [Abstract] [Full Text] [Related]
2. Selective interference of beta-arrestin 1 with kappa and delta but not mu opioid receptor/G protein coupling. Cheng ZJ, Yu QM, Wu YL, Ma L, Pei G. J Biol Chem; 1998 Sep 18; 273(38):24328-33. PubMed ID: 9733719 [Abstract] [Full Text] [Related]
3. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, O'Dowd BF. J Biol Chem; 2000 Aug 25; 275(34):26128-35. PubMed ID: 10842167 [Abstract] [Full Text] [Related]
4. Endogenous RGS protein action modulates mu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways. Clark MJ, Harrison C, Zhong H, Neubig RR, Traynor JR. J Biol Chem; 2003 Mar 14; 278(11):9418-25. PubMed ID: 12524446 [Abstract] [Full Text] [Related]
5. Hetero-oligomers of alpha2A-adrenergic and mu-opioid receptors do not lead to transactivation of G-proteins or altered endocytosis profiles. Zhang YQ, Limbird LE. Biochem Soc Trans; 2004 Nov 14; 32(Pt 5):856-60. PubMed ID: 15494033 [Abstract] [Full Text] [Related]
6. Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells. Alt A, Clark MJ, Woods JH, Traynor JR. Br J Pharmacol; 2002 Jan 14; 135(1):217-25. PubMed ID: 11786497 [Abstract] [Full Text] [Related]
7. Selective interactions of mu-opioid receptors with pertussis toxin-sensitive G proteins: involvement of the third intracellular loop and the c-terminal tail in coupling. Georgoussi Z, Merkouris M, Mullaney I, Megaritis G, Carr C, Zioudrou C, Milligan G. Biochim Biophys Acta; 1997 Dec 12; 1359(3):263-74. PubMed ID: 9434132 [Abstract] [Full Text] [Related]
8. The bovine mu-opioid receptor: cloning of cDNA and pharmacological characterization of the receptor expressed in mammalian cells. Onoprishvili I, Andria ML, Vilim FS, Hiller JM, Simon EJ. Brain Res Mol Brain Res; 1999 Nov 10; 73(1-2):129-37. PubMed ID: 10581406 [Abstract] [Full Text] [Related]
9. Mu-delta opioid receptor functional interaction: Insight using receptor-G protein fusions. Snook LA, Milligan G, Kieffer BL, Massotte D. J Pharmacol Exp Ther; 2006 Aug 10; 318(2):683-90. PubMed ID: 16690720 [Abstract] [Full Text] [Related]
10. Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: coupling to multiple G proteins. Chan JS, Chiu TT, Wong YH. J Neurochem; 1995 Dec 10; 65(6):2682-9. PubMed ID: 7595566 [Abstract] [Full Text] [Related]
11. Region-dependent G-protein activation by mu-, delta 1- and delta 2-opioid receptor agonists in the brain: comparison between the midbrain and forebrain. Tsuji M, Narita M, Mizoguchi H, Narita M, Ohsawa M, Kamei J, Nagase H, Takeda H, Matsumiya T, Tseng LF. Life Sci; 1999 Dec 10; 65(16):PL233-9. PubMed ID: 10573190 [Abstract] [Full Text] [Related]
12. Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors. Shapira M, Vogel Z, Sarne Y. Cell Mol Neurobiol; 2000 Jun 10; 20(3):291-304. PubMed ID: 10789829 [Abstract] [Full Text] [Related]
13. SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [35S]-GTP-gamma-S binding at cloned opioid receptors. Xu H, Lu YF, Rice KC, Ananthan S, Rothman RB. Brain Res Bull; 2001 Jul 01; 55(4):507-11. PubMed ID: 11543951 [Abstract] [Full Text] [Related]
14. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment. Noble F, Cox BM. Br J Pharmacol; 1996 Jan 01; 117(1):161-9. PubMed ID: 8825358 [Abstract] [Full Text] [Related]
15. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells. Clark MJ, Traynor JR. J Pharmacol Exp Ther; 2005 Feb 01; 312(2):809-15. PubMed ID: 15383633 [Abstract] [Full Text] [Related]
16. Nucleoside diphosphate kinase associated with membranes modulates mu-opioid receptor-mediated [35S]GTPgammaS binding and agonist binding to mu-opioid receptor. Zhang D, Li JG, Chen C, Liu-Chen LY. Eur J Pharmacol; 1999 Jul 21; 377(2-3):223-31. PubMed ID: 10456435 [Abstract] [Full Text] [Related]
17. Standard opioid agonists activate heteromeric opioid receptors: evidence for morphine and [d-Ala(2)-MePhe(4)-Glyol(5)]enkephalin as selective μ-δ agonists. Yekkirala AS, Kalyuzhny AE, Portoghese PS. ACS Chem Neurosci; 2010 Feb 17; 1(2):146-54. PubMed ID: 22816017 [Abstract] [Full Text] [Related]
18. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment. Liu JG, Prather PL. Mol Pharmacol; 2001 Jul 17; 60(1):53-62. PubMed ID: 11408600 [Abstract] [Full Text] [Related]